RF Technology Effective in Treating Lung Cancer RITA Medical Systems, Inc. (Nasdaq: RITA) announced today that the results of a clinical study on the use of its proprietary radiofrequency (RF) ablation technology confirm that the minimally invasive treatment appears to be effective in treating cancerous lung tumors when surgery is not an option, which is the case for the majority of lung cancer patients http://groups.yahoo.com/group/experimentalandunconventional/message/806
RFA for Bone Lesions Radio-frequency ablation of metastatic bone lesions provides durable pain relief December 3, 2002. Results of a multicenter study indicate that percutaneous radio-frequency ablation (RFA) of osteolytic metastatic lesions "can achieve dramatic reductions in pain while improving quality of life." http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&Year=2002&Month=12&id=9114
Radiofrequency appears superior to cryosurgery in preventing liver metastases January 2, 2003 As a treatment for unresectable hepatic malignancies, percutaneous radiofrequency (PRF) and cryosurgery (PCS) have comparable initial success and complication rates, but PRF appears to be better than PCS at preventing recurrent disease, according to a recent report http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&Year=2003&Month=01&id=9220